Morgan Stanley »

Galmed Pharmaceuticals shares owned by Morgan Stanley

Quarter-by-quarter ownership of Galmed Pharmaceuticals (GLMD) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Galmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Galmed Pharmaceuticals held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galmed Pharmaceuticals by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $10k 36k 0.28
2024-03-31 $5.0k 15k 0.35
2023-12-31 $38k 83k 0.45
2023-09-30 $12k 20k 0.62
2023-06-30 $37k 13k 2.99

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)

View all positions for Morgan Stanley

Top funds holding Galmed Pharmaceuticals

CVI Holdings
Morgan Stanley
Two Sigma Securities

View all funds holding Galmed Pharmaceuticals